BioSpace News Archive

Business

Organogenesis Holdings Inc. Reports First Quarter 2021 Financial Results

Organogenesis Holdings Inc., a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, reported financial results for the three months ended March 31, 2021.

May 10, 2021
·
17 min read
Business

Sigilon Therapeutics Reports First Quarter 2021 Financial Results and Business Highlights

Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics™ platform, today reported financial results for the first quarter ended March 31, 2021 as well as certain other business highlights.

May 10, 2021
·
10 min read
Business

Seer Reports First Quarter 2021 Financial Results

Second Phase of Commercialization Advances with the Addition of Multiple Limited Release Customers

May 10, 2021
·
5 min read
Business

Larimar Therapeutics Reports First Quarter 2021 Operating and Financial Results

Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today reported its first quarter 2021 operating and financial results.

May 10, 2021
·
7 min read
Business

Gracell Biotechnologies Appoints Seasoned Gene & Cell Therapy Executive Dr. Jenny (Yajin) Ni as Chief Technology Officer

Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced the appointment of Dr. Jenny (Yajin) Ni as its Chief Technology Officer (CTO).

May 10, 2021
·
5 min read
Business

Surgalign Holdings, Inc. Announces First Quarter 2021 Results

Surgalign Spine Technologies, a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, reported operating results for the first quarter of 2021.

May 10, 2021
·
16 min read
Business

NuVasive Appoints Juliet C. Cunningham as Vice President of Investor Relations

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the appointment of Juliet C. Cunningham as the vice president of Investor Relations, effective immediately

May 10, 2021
·
3 min read
Business

AcelRx to Host First Quarter 2021 Financial Results Call and Webcast on May 17, 2021

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company, today announced that it will release first quarter financial results after market close on Monday, May 17, 2021

May 10, 2021
·
1 min read
Business

INOVIO Reports First Quarter 2021 Financial Results

INOVIOINOVIO, a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, reported financial results for the quarter ended March 31, 2021.

May 10, 2021
·
24 min read
Deals

Culmina Ventures Announces Agreement for Acquisition of ClearMynd Technology Solutions Corp.

Culmina Ventures Corp., is pleased to announce that on April 29, 2021, the Company entered into a definitive share exchange agreement with ClearMynd Technology Solutions Corp. and its securityholders in respect of its proposed acquisition of all the issued and outstanding securities of ClearMynd.

May 10, 2021
·
2 min read